Compile Data Set for Download or QSAR
maximum 50k data
Found 60 with Last Name = 'flaumenhaft' and Initial = 'r'
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271332(US10064853, Compound 1)
Affinity DataIC50:  250nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271332(US10064853, Compound 1)
Affinity DataIC50:  250nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386391(CHEMBL1411333)
Affinity DataIC50:  260nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386409(CHEMBL2047299)
Affinity DataIC50:  290nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386408(CHEMBL2047297)
Affinity DataIC50:  340nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386400(CHEMBL2049115)
Affinity DataIC50:  380nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386398(CHEMBL2049113)
Affinity DataIC50:  390nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386397(CHEMBL2049112)
Affinity DataIC50:  480nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386406(CHEMBL1718628)
Affinity DataIC50:  520nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386394(CHEMBL2048423)
Affinity DataIC50:  520nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386399(CHEMBL2049114)
Affinity DataIC50:  600nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271339(US10064853, Compound 14)
Affinity DataIC50:  650nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271339(US10064853, Compound 14)
Affinity DataIC50:  650nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386395(CHEMBL2048425)
Affinity DataIC50:  710nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386393(CHEMBL1721173)
Affinity DataIC50:  770nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271338(US10064853, Compound 13)
Affinity DataIC50:  850nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271338(US10064853, Compound 13)
Affinity DataIC50:  850nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386389(CHEMBL1729550)
Affinity DataIC50:  970nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386390(CHEMBL1734760)
Affinity DataIC50:  1.10E+3nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386410(CHEMBL2047300)
Affinity DataIC50:  1.12E+3nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386392(CHEMBL2048420)
Affinity DataIC50:  1.29E+3nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386405(CHEMBL2049121)
Affinity DataIC50:  1.41E+3nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386404(CHEMBL1332325)
Affinity DataIC50:  1.68E+3nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386411(CHEMBL2047284)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386396(CHEMBL2048430)
Affinity DataIC50:  2.20E+3nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271337(US10064853, Compound 9)
Affinity DataIC50:  2.25E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271337(US10064853, Compound 9)
Affinity DataIC50:  2.25E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386401(CHEMBL2049116)
Affinity DataIC50:  2.28E+3nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386407(CHEMBL2047286)
Affinity DataIC50:  2.64E+3nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645352(Maackiaflavanone | US20240016777, Table1a.2)
Affinity DataIC50:  3.00E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386403(CHEMBL2049118)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271341(US10064853, Compound 16)
Affinity DataIC50:  3.00E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271341(US10064853, Compound 16)
Affinity DataIC50:  3.00E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50386402(CHEMBL2049117)
Affinity DataIC50:  3.12E+3nMAssay Description:Inhibition of SFLLRN-NH2-stimulated PAR1-mediated platelet activation in platelet-rich human plasma assessed as surface expression of P-selectin afte...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271342(US10064853, Compound 17)
Affinity DataIC50:  4.00E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271342(US10064853, Compound 17)
Affinity DataIC50:  4.00E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645355(5,7,2',4'- Tetrahydroxy-3- geranylflavone | US2024...)
Affinity DataIC50:  5.00E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645353(Kushenol C | US20240016777, Table1a.3)
Affinity DataIC50:  5.50E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645364(US20240016777, Table3.6 | pinocembrin 7-O-(3$#8243...)
Affinity DataIC50:  6.00E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645361(US20240016777, Table2a.1 | furowanin A)
Affinity DataIC50:  7.00E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM429466(US20240016777, Table3.7 | acs.jmedchem.1c00409_ST....)
Affinity DataIC50:  8.00E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645366(Jaceidin triacetate | US20240016777, Table3.8)
Affinity DataIC50:  1.20E+4nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645360(Multicaulisin | US20240016777, Table1d.1)
Affinity DataIC50:  1.70E+4nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645354(8- Lavandulylkaempferol | US20240016777, Table1a.5)
Affinity DataIC50:  1.95E+4nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271344(US10064853, Compound 19)
Affinity DataIC50:  2.25E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271344(US10064853, Compound 19)
Affinity DataIC50:  2.25E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271343(US10064853, Compound 18)
Affinity DataIC50: >3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271340(US10064853, Compound 15)
Affinity DataIC50: >3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271336(US10064853, Compound 8)
Affinity DataIC50: >3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein disulfide-isomerase(Homo sapiens (Human))
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271343(US10064853, Compound 18)
Affinity DataIC50: >3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 60 total ) | Next | Last >>
Jump to: